Angela C Webster
Angela C Webster, MBBS, PhD, FRCP is an expert in Nephrology at Westmead Hospital (Australia). As of September 2026, ScienceLeadR ranks Angela C Webster in the top 1% of experts worldwide for Epidemiologic Studies. Angela C Webster has authored 406 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 1,375 (community average: 125). How the SLR is computed.
LeadR Profile
Nephrology
Subspecialties: Transplantation - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 406
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Decentralised oncology trials: decentralisation as a tool, not the goal. PMID 42781060 | BMJ Oncol | 2026 | 0 |
| From the Cochrane library: Interventions for itch in people with advanced chronic kidney disease. PMID 42461874 — kidney diseases, kidney, skin diseases | Dermatology | 2026 | 0 |
| Impact of Perfusion With Methylene Blue on Perioperative Bleeding in Simultaneous Pancreas and Kidney Transplantation: A Randomized Control Trial. PMID 42404283 — diabetes mellitus, blood transfusion, hemorrhage, blood, methylene blue, kidney, pancreas, transplants, kidney transplantation, transplantation | Transplant Direct | 2026 | 0 |
| Skin cancer mortality in Australian and New Zealand kidney transplant recipients: A population-based cohort study using linked health data, 1990-2019. PMID 42243641 — skin, mortality, syphilis, melanoma, geography, neoplasms, cohort studies, kidney, sex, transplants, dermatology, demography, skin neoplasms | Br J Dermatol | 2026 | 0 |
| Steroid avoidance or withdrawal for kidney transplant recipients. PMID 42187003 — diabetes mellitus, bias, kidney, biopsy, tacrolimus, maintenance, transplants, research, therapeutics, steroids, antimetabolites, transplantation, infections | Cochrane Database Syst Rev | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin) NCT05860881 — skin, cells, pharmaceutical preparations, carcinoma, squamous cell, neoplasms, sirolimus, chemoprevention, counterfeit drugs, transplants, pharmaceutical vehicles, skin neoplasms, carcinoma | Phase 3 | Active not recruiting | 2024 |
LeadR Networks
Main global connection map